Delivery Order SPE2DB20D1109-SPE2DB22FN63L
Award Date 2/16/22
Potential Completion Date 2/17/22
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, including Vyvanse 50 mg capsules, to support government healthcare programs. The $4,628.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of March 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides $1,841.30 for the delivery of Vyvanse 30 mg capsules to support the Defense Logistics Agency (DLA) Troop Support Medical. The award, with an ultimate completion date of April 24, 2023, is structured as a firm fixed-price Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,337.89 firm fixed-price delivery order is for the supply of 4,563,447,787 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $2,603.07 for the supply of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of February 28, 2025 and is a firm fixed price arrangement. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,347.36 for the supply of Vyvanse 50 mg capsules. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,817.79 for the supply of VYVANSE 10 MG CAPSULE 100S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of April 24, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $60,892.57 for the supply of Vyvanse capsules 40mg. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract has an ultimate completion date of May 5, 2023 and is a firm fixed-price arrangement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,792.64 issued by the Defense Logistics Agency (DLA) for the supply of 4,553,492,506 units of VYVANSE 40 MG CAPSULE 100S. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,936.73 Firm Fixed Price Delivery Order covers the supply of 4,561,986,301 units of the pharmaceutical product VYVANSE 30 MG CAPSULE 100S. The award has an ultimate completion date of August 30, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...
- This federal contract award, valued at $1,724.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for 4564398222 - Vyvanse 20 mg capsules, with an ultimate completion date of April 26, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...